APA (7th ed.) Citation

P, H., AT, P., JC, V., C, M., J, K., J, R., . . . S, S. (2019). Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial. JAMA ophthalmology, 137(11), 1256. https://doi.org/10.1001/jamaophthalmol.2019.3305

Chicago Style (17th ed.) Citation

P, Hykin, et al. "Clinical Effectiveness of Intravitreal Therapy With Ranibizumab Vs Aflibercept Vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial." JAMA Ophthalmology 137, no. 11 (2019): 1256. https://doi.org/10.1001/jamaophthalmol.2019.3305.

MLA (9th ed.) Citation

P, Hykin, et al. "Clinical Effectiveness of Intravitreal Therapy With Ranibizumab Vs Aflibercept Vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial." JAMA Ophthalmology, vol. 137, no. 11, 2019, p. 1256, https://doi.org/10.1001/jamaophthalmol.2019.3305.